Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

iBio plans to use the offering's net proceeds for general co...

iBio plans to use the offering's net proceeds for general corporate purposes, including R&D and working capital. The funds are expected to extend the company's cash runway through 2025. CEO Martin Brenner thanked healthcare specialist investors for their support.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
2
+0
Translate
Report
3512 Views
Comment
Sign in to post a comment